Key Takeaways

  • Jared Rutter identified MPC1 and MPC2, solving a 60-year mystery around how pyruvate enters mitochondria across yeast, fruit flies, and mammals.
  • Cells balance a strict trade-off: burn incoming fuel to produce ATP energy, or divert those carbon skeletons into building new biomass.
  • Deleting MPC in mouse hearts stripped cardiomyocytes of their ability to burn glucose efficiently inside mitochondria.
  • Denied energy production, the heart cells rewired their metabolism into pathological growth, triggering massive cardiac enlargement and lethal heart failure within weeks.

The 60-Year Biochemical Mystery

For more than half a century, biochemists knew that pyruvate had to cross the inner mitochondrial membrane to feed the Krebs cycle and make energy. The actual gatekeeper remained completely invisible.

“It's been known for 60 or 70 years that mitochondria must have a carrier to enable pyrovate to get in. But it was not identified what that protein was, how it worked,” explains Jared Rutter.

By running genetic screens across yeast, Drosophila, and mammalian cells, Rutter and his lab tracked down the exact machinery: two tiny proteins named MPC1 and MPC2. “Everything that has a mitochondria has these two NPC1 and NPC2 proteins,” Rutter notes. “MPC, aptly named is the carrier that enables pyrovate to get into the mitochondria. Mitochondrial pyrovate carrier. That's what it does.”

Without these twin carriers, the cell cannot push the end product of glycolysis into the mitochondrial engine room. The gateway simply shuts.

When Cells Pick Growth Over Energy

To see what happens when an organ loses this fuel line, Rutter engineered mice lacking MPC strictly in their heart muscle. The result was not an instant shutdown of the organ. Instead, the tissue adapted in a destructive direction.

“What essentially happens to that heart is that it lives and the animal lives for weeks after that. But eventually the animals die. And when you look at what they die of, they have a massive heart. They die of heart failure,” Rutter says.

The mechanism reveals a basic metabolic rule. When a cell cannot burn fuel to generate energy, it channels those raw inputs into physical tissue.

“Instead of using the glucose that they take in to burn it and make ATP, they start making biomass,” Rutter explains. “We've eliminated their ability to make ATP from it at least as effectively and instead they make biomass. They grow.”

The heart cells ballooned in size because they could no longer convert glucose into usable work. That uncontrolled growth dilated the ventricles and destroyed the heart's mechanical output. The same bifurcation shows up in cancer biology: when normal oxidative metabolism stalls, cells default to rapid, runaway expansion.

What to Do With This

Map your current projects against the energy versus biomass trade-off. When a team or system loses its primary conversion path (direct cash flow or clear customer value), it almost always redirects excess resources into structural bloat (headcount, extra tooling, and process). Audit your three biggest overhead expenses this Friday. If an initiative is consuming inputs without generating measurable operational output, cut it before the resulting bloat breaks your system.